Teleflex Incorporated
As of Oct 22, 2026, Teleflex is in Stage 3, the topping phase, now in week 4 (since Sep 30, 2026). It closed at $136.58, 3.9% below its 52-week high and above its 200-day average, which is rising.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is TFX early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
TFX among Medical Instruments & Supplies22nd of 51 by relative strength
All 51 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | PLSE | Stage 2 · wk 34 | 98 | +1.3% |
| 2 | PDEX | Stage 2 · wk 36 | 97 | −13.3% |
| 3 | HBIO | Stage 2 · wk 11 | 95 | +3.6% |
| 4 | ATRC | Stage 2 · wk 10 | 89 | −1.1% |
| 5 | WST | Stage 2 · wk 24 | 82 | +4.8% |
| 6 | BDX | Stage 2 · wk 11 | 81 | +9.8% |
| 7 | ICUI | Stage 3 · wk 1 | 81 | +3.1% |
| 8 | OSUR | Stage 3 · wk 8 | 75 | −4.8% |
| …22 | TFX | Stage 3 · wk 4 | 58 | +12.2% |
Teleflex: quick answers
What stage is Teleflex in?
As of Oct 22, 2026, Teleflex (TFX) is in Stage 3, the topping phase. It entered Stage 3 on Sep 30, 2026 and is in week 4. What the four stages mean
Is Teleflex in an uptrend?
Its uptrend has stalled. Teleflex is in Stage 3, the topping phase that follows an advance. It trades 10.2% above its 200-day average, which is rising.
How far is Teleflex from its 52-week high?
Teleflex closed at $136.58 on Oct 22, 2026, 3.9% below its 52-week high of $142.05. Its 52-week low is $99.54.
How has Teleflex performed over the past year?
As of Oct 22, 2026, Teleflex is up 3.8% over the past year and up 12.5% so far in 2026.
Which sector and industry is Teleflex in?
Teleflex is in the Medical Instruments & Supplies industry, part of the Health Care sector.
About this companyHealth Care· Medical Instruments & Supplies
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.